Average Co-Inventor Count = 5.77
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (27 from 329 patents)
2. Icos Corporation (11 from 164 patents)
3. Ventirx Pharmaceuticals, Inc. (6 from 10 patents)
4. Mirati Therapeutics, Inc. (4 from 38 patents)
5. Pfizer Corporation (3 from 4,455 patents)
6. Takeda Pharmaceutical Company Limited (3 from 1,179 patents)
7. Celgene Corporation (2 from 550 patents)
8. Luitpold Pharmaceuticals, Inc. (2 from 19 patents)
45 patents:
1. 11267812 - KRAS G12C inhibitors
2. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
3. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
4. 10689377 - KRas G12C inhibitors
5. 10633381 - KRas G12C inhibitors
6. 10189845 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
7. 10125134 - KRas G12C inhibitors
8. 9718796 - Substituted benzoazepines as toll-like receptor modulators
9. 9655904 - Substituted benzoazepines as toll-like receptor modulators
10. 9556139 - 6-substituted phenoxychroman carboxylic acid derivatives
11. 9242964 - Substituted benzoazepines as toll-like receptor modulators
12. 9126940 - Substituted benzoazepines as toll-like receptor modulators
13. 9096567 - 6-substituted phenoxychroman carboxylic acid derivatives
14. 8962596 - 5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases
15. 8785445 - 7-phenoxychroman carboxylic acid derivatives